Brad Hively - 17 Nov 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Issuer symbol
TOI
Transactions as of
17 Nov 2023
Net transactions value
-$34,750
Form type
4
Filing time
21 Nov 2023, 19:27:35 UTC
Previous filing
15 Nov 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Options Exercise $21,250 +25,000 +3.6% $0.8500 722,065 17 Nov 2023 Direct
transaction TOI Common stock Sale $56,000 -25,000 -3.5% $2.24 697,065 17 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 -25,000 -1.4% $0.000000 1,745,431 17 Nov 2023 Common stock 25,000 $0.8500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.